Is rivaroxaban associated with higher morbidity and mortality in patients with traumatic head injuri...
Is rivaroxaban associated with higher morbidity and mortality in patients with traumatic head injuries? A retrospective cohort study comparing rivaroxaban, no anticoagulation, and phenprocoumon
About this item
Full title
Author / Creator
Publisher
Netherlands: Elsevier B.V
Journal title
Language
English
Formats
Publication information
Publisher
Netherlands: Elsevier B.V
Subjects
More information
Scope and Contents
Contents
•Potential association of new anticoagulants with morbidity or intracranial bleeding.•Retrospective cohort study (3 groups: rivaroxaban, no anticoagulant, phenprocoumon).•No significant differences in morbidity or intracranial bleeding (n = 69).•One patient died likely due to head trauma in rivaroxaban group, but no patient died likely due to head...
Alternative Titles
Full title
Is rivaroxaban associated with higher morbidity and mortality in patients with traumatic head injuries? A retrospective cohort study comparing rivaroxaban, no anticoagulation, and phenprocoumon
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2025316957
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2025316957
Other Identifiers
ISSN
0303-8467
E-ISSN
1872-6968
DOI
10.1016/j.clineuro.2018.04.001
